Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vical
Vical
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha
Fri, 05/3/13 - 12:57 pm
Vical
Amgen
Bristol-Myers Squibb
OncoSec
ImmunoCellular Therapeutics
Roche
NCT00395070
melanoma
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tue, 04/23/13 - 03:31 pm
melanoma
vaccines
Amgen
Celldex
Oncothyreon
OncoSec
Vical
Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha
Thu, 03/28/13 - 10:38 am
Amgen
Vical
melanoma
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Tue, 02/19/13 - 10:12 am
immunotherapy
Celgene
Bristol-Myers Squibb
OncoSec
ONYX Pharmaceuticals
Vical
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
Why Vical Will Keep Plunging
Motley Fool
Sat, 12/22/12 - 12:27 pm
Vical
Glaxo's Genital Herpes Vaccine Flops But Genocea's Next-Generation Approach Makes It A Buy
Seeking Alpha
Sun, 12/16/12 - 10:37 am
GSK
herpes
genital herpes
Genocea Biosciences
Agenus
Sanofi
Vical
vaccines
OncoSec Medical: 2013 Will Be A Year Of Crucial Events
Seeking Alpha
Thu, 12/6/12 - 05:33 pm
OncoSec Medical
Amgen
Dendreon
Vical
Bristol-Myers Squibb
Vical says privately held Cyvax will use its Vaxfectin technology in malaria vaccines
Yahoo/AP
Wed, 12/5/12 - 12:06 pm
Vical
malaria
vaccines
Vaxfectin
Cyvax
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha
Thu, 11/8/12 - 10:50 am
Vical
Allovectin
Bristol-Myers Squibb
JNJ
melanoma
Vical and Bristol-Myers Ink Deal
Yahoo/Zacks
Mon, 09/17/12 - 03:50 pm
Vical
Bristol-Myers Squibb
Vaxfectin
Vical's Vaxfectin Comes Alive
Seeking Alpha
Thu, 09/13/12 - 04:03 pm
Vaxfectin
Vical
Bristol-Myers Squibb
metastatic melanoma
3 Vaccine Companies With Upcoming Catalysts
Seeking Alpha
Sun, 09/9/12 - 11:05 am
Sinovac Biotech
Dynavax Technologies
Vical
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
3 Speculative Biotechs Worth Watching
Seeking Alpha
Sun, 07/8/12 - 01:07 pm
OncoSec
Vical
Sangamo BioSciences
Melanoma Treatments Look To Benefit From Large Market
Seeking Alpha
Tue, 07/3/12 - 11:46 am
Amgen
Bristol-Myers Squibb
GSK
OncoSec
Vical
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
Vical: An Update On My $3 Biotech Lottery Ticket
Seeking Alpha
Wed, 05/2/12 - 11:08 am
Vical
earnings
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Thu, 03/22/12 - 11:35 am
Amyris
Aveo
China Biologic
Chelsea Therapeutics
Pluristem
Spectrum Pharmaceuticals
Questcor
Theravance
Vical
Zalicus
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Mon, 03/12/12 - 08:44 pm
Vical
Allovectin
metastatic melanoma
melanoma
Zytiga
JNJ
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »